Ann-Kathrin Eisfeld

893 total citations
6 papers, 137 citations indexed

About

Ann-Kathrin Eisfeld is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ann-Kathrin Eisfeld has authored 6 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 3 papers in Genetics and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ann-Kathrin Eisfeld's work include Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Ann-Kathrin Eisfeld is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Ann-Kathrin Eisfeld collaborates with scholars based in United States and Germany. Ann-Kathrin Eisfeld's co-authors include Clara D. Bloomfield, Krzysztof Mrózek, Richard M. Stone, Jonathan E. Kolitz, Jessica Kohlschmidt, Eunice S. Wang, John C. Byrd, Wendy Stock, Geoffrey L. Uy and Richard A. Larson and has published in prestigious journals such as Genome Research, Journal of Hematology & Oncology and Blood Advances.

In The Last Decade

Ann-Kathrin Eisfeld

6 papers receiving 134 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann-Kathrin Eisfeld United States 6 94 89 30 23 15 6 137
Tomoaki Kitano Japan 5 79 0.8× 72 0.8× 23 0.8× 33 1.4× 17 1.1× 6 120
Kristen Meldi United States 4 111 1.2× 112 1.3× 20 0.7× 41 1.8× 15 1.0× 6 166
Valeria Cardinali Italy 3 82 0.9× 76 0.9× 15 0.5× 13 0.6× 16 1.1× 14 110
Aino‐Maija Leppä Germany 3 101 1.1× 75 0.8× 15 0.5× 28 1.2× 16 1.1× 10 129
Patee Gesuwan United States 4 93 1.0× 68 0.8× 45 1.5× 12 0.5× 27 1.8× 7 121
Y. Lucy Liu United States 6 97 1.0× 102 1.1× 14 0.5× 52 2.3× 14 0.9× 15 153
Matthieu Duchmann France 4 61 0.6× 46 0.5× 18 0.6× 26 1.1× 10 0.7× 11 92
Harald Polzer Germany 6 111 1.2× 83 0.9× 10 0.3× 39 1.7× 13 0.9× 9 141
Evan Massi United States 3 116 1.2× 75 0.8× 17 0.6× 40 1.7× 12 0.8× 3 134
Bruno A. Lopes Brazil 7 54 0.6× 71 0.8× 20 0.7× 15 0.7× 45 3.0× 20 126

Countries citing papers authored by Ann-Kathrin Eisfeld

Since Specialization
Citations

This map shows the geographic impact of Ann-Kathrin Eisfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann-Kathrin Eisfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann-Kathrin Eisfeld more than expected).

Fields of papers citing papers by Ann-Kathrin Eisfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann-Kathrin Eisfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann-Kathrin Eisfeld. The network helps show where Ann-Kathrin Eisfeld may publish in the future.

Co-authorship network of co-authors of Ann-Kathrin Eisfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Ann-Kathrin Eisfeld. A scholar is included among the top collaborators of Ann-Kathrin Eisfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann-Kathrin Eisfeld. Ann-Kathrin Eisfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Chen, Evan C., Shuli Li, Ann-Kathrin Eisfeld, et al.. (2021). Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 27(6). 479.e1–479.e7. 10 indexed citations
2.
Mims, Alice S., Jessica Kohlschmidt, Uma Borate, et al.. (2021). A precision medicine classification for treatment of acute myeloid leukemia in older patients. Journal of Hematology & Oncology. 14(1). 96–96. 10 indexed citations
3.
Giacopelli, Brian, Min Wang, Yue-Zhong Wu, et al.. (2021). DNA methylation epitypes highlight underlying developmental and disease pathways in acute myeloid leukemia. Genome Research. 31(5). 747–761. 27 indexed citations
4.
Walker, Alison R., Guido Marcucci, Jun Yin, et al.. (2021). Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance). Blood Advances. 5(13). 2775–2787. 23 indexed citations
5.
Walker, Christopher J., Krzysztof Mrózek, Hatice Gülçin Özer, et al.. (2021). Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia. Blood Advances. 5(5). 1474–1482. 22 indexed citations
6.
Marcucci, Guido, Susan M. Geyer, Kristina Laumann, et al.. (2020). Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801. Blood Advances. 4(4). 696–705. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026